RIGL

Rigel Pharmaceuticals, Inc. News Headlines

$3.27
*  
0.14
4.11%
Get RIGL Alerts
*Delayed - data as of Jul. 31, 2014  -  Find a broker to begin trading RIGL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Rigel Pharmaceuticals Starts Fostamatinib Late Stage Program - Analyst Blog
7/17/2014 4:45:00 PM - Zacks.com

GNCA Withdraws Stock Offering, POZN Gets FDA Date, CNCE On Watch
7/16/2014 10:30:00 PM - RTT News

Rigel Pharma To Present At Jefferies Conference; Webcast At 2:30 PM ET
6/3/2014 1:30:00 PM - RTT News

Is Rigel Pharmaceuticals (RIGL) Stock a Solid Choice Right Now? - Tale of the Tape
4/11/2014 8:46:01 AM - Zacks.com

Looking For Value Among Biotechs After Precipitous Declines In Stock Price
3/24/2014 12:26:00 PM - Seeking Alpha

Rigel (RIGL) Worth Watching: Stock Rises 10.2% - Tale of the Tape
3/7/2014 10:46:01 AM - Zacks.com

Rigel Rises on Narrower Q4 Loss - Analyst Blog
3/6/2014 10:40:01 AM - Zacks.com

Pre-Market Earnings Report for March 4, 2014 : BNS, AZO, HTH, TSL, SSP, BRLI, TRIB, JRN, GTIV, MCGC, RIGL, RSH
3/3/2014 5:00:01 PM - NASDAQ.com News

Rigel Narrows Loss, Shares Continue to Fall - Analyst Blog
11/12/2013 4:05:32 PM - Zacks.com

Rigel Pharma Trims Workforce - Analyst Blog
9/10/2013 6:45:01 PM - Zacks.com

Sector Update: Healthcare Shares Lower; Rigel Plunges to New 52-Wk Low on Rationalization Plans
9/5/2013 8:08:18 AM - MT Newswires

Sector Update: Healthcare
9/5/2013 8:04:51 AM - MT Newswires

Rigel Down on Phase II Setback - Analyst Blog
8/27/2013 1:30:01 PM - Zacks.com

Yet Another Failure Has Rigel Pharmaceuticals Almost Back To Square One
8/26/2013 3:15:00 PM - Investopedia

Rigel Pharma Narrows Q2 Loss - Analyst Blog
8/7/2013 11:41:00 AM - Zacks.com

AstraZeneca to Return Fostamatinib Rights - Analyst Blog
6/5/2013 5:28:45 PM - Zacks.com

Pre-Market Most Active for Jun 4, 2013 : ET, ING, NOK, ZNGA, ASML, BAC, UBS, MTU, RIGL, GRFS, QQQ, INFI
6/4/2013 8:39:59 AM - NASDAQ.com News

A Journey To Add Biotech To The Portfolio
5/18/2013 2:38:00 AM - Seeking Alpha

Narrower-Than-Expected Loss at Rigel Pharma - Analyst Blog
5/9/2013 10:00:01 AM - Zacks.com

AZN Reports Data on Fostamatinib - Analyst Blog
4/8/2013 7:08:59 PM - Zacks.com

Small Pharma Watch List: Week Of April 8, 2013
4/8/2013 11:03:00 AM - Seeking Alpha

Today's Market News To Trade On: 5 Stocks Moving On News
4/8/2013 9:02:00 AM - Seeking Alpha

AstraZeneca's Arthritis Pill Disappoints in Late-Stage Trial
4/5/2013 10:40:00 AM - Fox Business

Mid-Morning Market Update: Markets Tumble, F5 Networks Cuts View
4/5/2013 10:12:43 AM - Benzinga

Pre-Market Most Active for Apr 5, 2013 : BAC, RIGL, QQQ, CSCO, MT, FB, SIRI, INTC, NOK, RDS/A, BDN, STO
4/5/2013 8:39:58 AM - NASDAQ.com News